|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2021 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III, JD |
Date | 10/20/2021 4:17:21 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 5305, Extending Government Funding and Delivering Emergency Assistance Act, provisions relating to extension of Conrad 30 program
S. 1685, A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings, all provisions
H.R. 3684, INVEST in America Act, provisions relating to physician payment
S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031, provisions relating to physician payment/Medicare program sustainability
H. Res. 601, Providing for consideration of the bill (H.R. 4) to amend the Voting Rights Act of 1965 to revise the criteria for determining which States and political subdivisions are subject to section 4 of the Act, and for other purposes; providing for consideration of the Senate amendment to the bill (H.R. 3684) to authorize funds for Federal-aid highways, highway safety programs, and transit programs, and for other purposes; and providing for the adoption of the concurrent resolution (S. Con. Res. 14) setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031; and for other purposes, provisions relating to physician payment/Medicare program sustainability
H.R. 5305, Extending Government Funding and Delivering Emergency Assistance Act, provisions relating to Conrad State 30 legislation
S. 54, Strengthening Americas Health Care Readiness Act, all provisions
FY2022 Labor, Health and Human Services, Education, and Related Agencies Subcommittee Appropriations, provisions relating to CDC breastfeeding line item, appropriate use criteria
FY2022 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations, provisions relating to Cigars and other tobacco products/FDA authority
American Rescue Plan Act/Access to healthcare coverage and lower health care costs
Build Back Better Act/PAYGO
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Alexis |
Pierce |
|
|
|
Kyle |
Thomson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 3352, Midwives for MOMS Act of 2021, all provisions
H.R. 4122, Resident Education Deferred Interest (REDI) Act, all provisions
H.R. 944, To amend the Public Health Service Act to authorize a loan repayment program to encourage specialty medicine physicians to serve in rural communities experiencing a shortage of specialty medicine physicians, and for other purposes, all provisions
H.R. 2225, National Science Foundation for the Future Act, all provisions
H.R. 2954, Securing a Strong Retirement Act of 2021, provisions relating to student loans
H.R. 2917, Retirement Parity for Student Loans Act of 2021, all provisions
S. 1443, Retirement Parity for Student Loans Act, all provisions
H.R. 3671, Doctors of Community (DOC) Act, all provisions
S. 1958, Doctors of Community (DOC) Act, all provisions
H.R. 2130, Rural America Health Corps Act, all provisions
S. 924, Rural America Health Corps Act, all provisions
H.R. 2418, Student Loan Forgiveness for Frontline Health Workers Act, all provisions
Physician workforce/Graduate Medical Education (GME)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
Christopher |
Sherin |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
|
Chase |
Thomas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 708, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, all provisions
S. 168, Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, all provisions
H.R. 4058, Telemental Health Care Access Act of 2021
S. 2061, Telemental Health Care Access Act of 2021, all provisions
H.R. 4480, Telehealth Coverage and Payment Parity Act, all provisions
H.R. 8, Bipartisan Background Checks Act of 2021, all provisions
H.R. 1446, Enhanced Background Checks Act of 2021, all provisions
H.R. 1306, National Coronavirus Commission Act of 2021, all provisions
S. 412, National Coronavirus Commission Act of 2021, all provisions
H.R. 1843, COVID-19 Hate Crimes Act, all provisions
S. 937, COVID-19 Hate Crimes Act, all provisions
H.R. 1667, Dr. Lorna Breen Health Care Provider Protection Act, all provisions
S. 610, Dr. Lorna Breen Health Care Provider Protection Act, all provisions
H.R. 3778, Nullifying Opportunities for Variants to Infect and Decimate (NOVID) Act, all provisions
S. 1976, Nullifying Opportunities for Variants to Infect and Decimate (NOVID) Act, all provisions
S. 2448, Health Misinformation Act of 2021, all provisions
H.R. 2503, Social Determinants Accelerator Act of 2021, all provisions
S. 509, Leveraging Integrated Networks in Communities (LINC) to Address Social Needs Act of 2021, all provisions
H.R. 2163, Safe Step Act, all provisions
S. 464, Safe Step Act, all provisions
H.R. 1384, Mainstreaming Addiction Treatment Act of 2021, all provisions
S. 445, Mainstreaming Addiction Treatment Act of 2021, all provisions
H.R. 925, Data to Save Moms Act, all provisions
H.R. 2547, Comprehensive Debt Collection Improvement Act, provisions relating to medical debt
H.R. 3755, Women's Health Protection Act of 2021, all provisions
S. 1975, Womens Health Protection Act of 2021, all provisions
H.R. 1816, Information Transparency & Personal Data Control Act, all provisions
H.R. 4217, Taskforce Recommending Improvements for Unaddressed Mental Perinatal & Postpartum Health (TRIUMPH) for New Moms Act of 2021, provision relating to physician representation
S. 2779, Taskforce Recommending Improvements for Unaddressed Mental Perinatal & Postpartum Health (TRIUMPH) for New Moms Act of 2021, provision relating to physician representation
S. 253, Cannabidiol and Marihuana Research Expansion Act, all provisions
H.R. 379, Improving Social Determinants of Health Act of 2021, all provisions
S. 104, Improving Social Determinants of Health Act of 2021, all provisions
H.R. 1218, Data Mapping to Save Moms Lives Act, all provisions
S. 198, Data Mapping to Save Moms Lives Act, all provisions
S. 1675, Maternal Health Quality Improvement Act, all provisions
H.R. 1384, Mainstreaming Addiction Treatment Act of 2021, all provisions
S. 445, Mainstreaming Addiction Treatment Act of 2021, all provisions
H.R. 666, Anti-Racism in Public Health Act of 2021, all provisions
S. 162, Anti-Racism in Public Health Act of 2021, all provisions
Comprehensive Addiction Resources Emergency (CARE) Act of 2019
21st Century Cures 2.0
Affordable Care Act Tax Credits
Primary and Virtual Health Care Affordability Act
Affordable Care Act family glitch
Waste, fraud, and abuse in telehealth
Digital Therapeutics
Digital Health/Artificial Intelligence (AI) regulation
Telehealth studies
Dialysis Centers/COVID-19 telehealth flexibilities continuation
Physician burnout and suicide issues
Vaccine distribution/vaccines in physician offices/health equity
Provider Relief Fund
Prior Authorization/attachment standards
ERISA Plans/prior authorization requirements
Health equity/race corrections in clinical algorithms
Maternal mortality
Prescription drug pricing
Data Privacy
Information blocking
Drug overdose epidemic
Social Determinants of Health
Cybersecurity and HIPAA
Clinical and administrative data
COVID-19/health equity/testing/PPE/misinformation/vaccine issues
COVID-19/OSHA/emergency temporary standard (ETS)
Precision Medicine/Diagnostics/Coding
Nomination of Rahul Gupta, MD, to be Director of White House Office of National Drug Control Policy
Mental health parity
Prior authorization
Physician health programs
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Drug Enforcement Administration (DEA), Justice - Dept of (DOJ), Natl Institute of Standards & Technology (NIST), Labor - Dept of (DOL), Health Resources & Services Administration (HRSA), Food & Drug Administration (FDA), White House Office, Federal Emergency Management Agency (FEMA), Centers For Disease Control & Prevention (CDC), Office of Science & Technology Policy (OSTP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Danielle |
Turnipseed |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Bryan |
Hull |
|
|
|
Alexis |
Pierce |
|
|
|
Kyle |
Thomson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R. 3541, Conrad State 30 and Physician Access Reauthorization Act, all provisions
S. 1810, Conrad State 30 and Physician Access Reauthorization Act, all provisions
H.R. 6, American Dream and Promise Act of 2021, all provisions
H.R. 2255, Healthcare Workforce Resilience Act, all provisions
S. 1024, Healthcare Workforce Resilience Act, all provisions
Alternative to Detention programs
Asylum seekers/health and well-being
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS), U.S. Customs & Border Protection
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Competition in Health Insurance
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1868, To prevent across-the-board direct spending cuts, and for other purposes, all provisions
H.R. 315, Medicare Sequester COVID Moratorium Act, all provisions
H.R. 1332, Telehealth Modernization Act, all provisions
S. 368, Telehealth Modernization Act, all provisions
H.R. 2903, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021, all provisions
S. 1512, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021, all provisions
H.R. 366, Protecting Access to Post-COVID-19 Telehealth Act of 2021, all provisions
H.R. 2166, Ensuring Parity in MA and PACE for Audio-Only Telehealth Act of 2021, all provisions
H.R. 2228, Rural Behavioral Health Access Act of 2021, all provisions
H.R. 3447, Permanency for Audio-Only Telehealth Act, all provisions
H.R. 5241, Linking Seniors to Needed Legal Services Act of 2021, all provisions
H.R. 3173, Improving Seniors Timely Access to Care Act of 2021, all provisions
H.R. 3259, Non-Opioids Prevent Addiction In the Nation (NOPAIN) Act, all provisions
S. 586, Non-Opioids Prevent Addiction In the Nation (NOPAIN) Act, all provisions
S. 987, CARA 3.0 Act of 2021, all provisions
H.R. 3441, Substance Use Disorder Workforce Act, all provisions
S. 1438, Opioid Workforce Act of 2021, all provisions
H.R. 3407, Mothers and Offspring Mortality and Morbidity Awareness (MOMMAs) Act, all provisions
S. 411, Mothers and Offspring Mortality and Morbidity Awareness (MOMMAs) Act, all provisions
H.R. 925, Data to Save Moms Act, all provisions
H.R. 2256, Resident Physician Shortage Reduction Act of 2021, all provisions
S. 834, Resident Physician Shortage Reduction Act of 2021, all provisions
H.R. 4014, Physician Shortage GME Cap Flex Act of 2021, all provisions
S. 2094, Physician Shortage GME Cap Flex Act of 2021, all provisions
H.R. 3746, Accountable Care in Rural America Act, all provisions
H.R. 4587, Value in Health Care Act of 2021, all provisions
H.R. 4755, Seniors Chronic Care Management Improvement Act of 2021, all provisions
H.R. 1330, Patient Access to Higher Quality Health Care Act of 2021, all provisions
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act, all provisions
H.R. 4043, Ensuring Patient Access to Critical Breakthrough Products Act of 2021, all provisions
S. 2416, NOVEL Act of 2021, all provisions
H.R. 2144, Access to Genetic Counselor Services Act of 2021, provisions relating to scope of practice
S. 1450, Access to Genetic Counselor Services Act of 2021, provisions relating to scope of practice
H.R. 2654, Chiropractic Medicare Coverage Modernization Act of 2021, provisions relating to scope of practice
H.R. 5370, Medically Tailored Home-Delivered Meals Demonstration Pilot Act of 202, all provisions
H.R. 2807, Promoting Responsible and Effective Virtual Experiences through Novel Technology to Deliver Improved Access and Better Engagement with Tested and Evidence-based Strategies (PREVENT DIABETES) Act, all provisions
S. 2173, Promoting Responsible and Effective Virtual Experiences through Novel Technology to Deliver Improved Access and Better Engagement with Tested and Evidence-based Strategies (PREVENT DIABETES) Act, all provisions
S. 748, Medicare Sequester Relief Act, all provisions
H.R. 955, Medicaid Reentry Act of 2021, all provisions
S. 285, Medicaid Reentry Act of 2021, all provisions
H.R. 19, Lower Costs, More Cures Act of 2021, provisions relating to pharmacy benefits managers and drug price transparency
S. 801, Connected MOM Act, all provisions
S. 346, Black Maternal Health Momnibus Act of 2021, all provisions
H.R. 1738, Stabilize Medicaid and CHIP Coverage Act, all provisions
H.R. 1025, Kids Access to Primary Care Act of 2021, all provisions
H.R. 66, Comprehensive Access to Robust Insurance Now Guaranteed (CARING) for Kids Act, all provisions
S. 2214, Promote Responsible Oversight and Targeted Employee background Check Transparency for Seniors (PROTECTS) Act, all provisions
H.R. 5125, Strengthening Innovation in Medicare and Medicaid Act, all provisions
H.R. 1587, Medicare Audiologist Access and Services Act of 2021, all provisions
S. 2691, Strengthening the Vaccines for Children Program Act of 2021, all provisions
Medicare program: No Surprises Act/implementation
Medicare program: Physician payment
Medicare program: 2022 Physician Fee Schedule/audio-only telehealth expansion
Medicare program: Telehealth Extension and Evaluation Act
Medicare program: Alternative payment models
Medicare program: National Coverage Determination/self-measured blood pressure monitoring devices
Medicare program: Physician payment issues/PAYGO and Sequester/3.75% Conversion Factor increase
Medicare program: Evaluation and Management (E/M)/budget neutrality
Medicare program: Physician-owned hospitals/hospital consolidation
Medicare program: Medicare expansion/dental, vision, hearing coverage
Medicare program: Diabetes Prevention
Medicare program: Surprise Medical Billing/Price transparency
Medicare program: Merit-Based Incentive Payment System (MIPS) program
Medicare program: MIPS Value Pathways
Medicare program: Quality Payment Program
Medicare program: Information blocking/interoperability/data segmentation
Medicare program: Cybersecurity and HIPAA
Medicare program: Measure Application Partnership (MAP)
Medicare program: COVID-19 Public Health Emergency/Accelerated and Advance Payments
Medicare program: Primary Care First (PCF) models
Medicare program: Medicare Shared Savings Program (MSSP)
Medicare program: Physician payment/globals
Medicare program: Provider Enrollment, Chain, and Ownership System (PECOS)/Revalidation
Medicare program: Open Payments
Medicare program: Prescription Drug Prices
Medicare program: Chronic Care Management code
Medicare program: Graduate Medical Education (GME)
Medicare program: Step Therapy
Medicare and Medicaid programs: Medicare Access and CHIP Reauthorization Act (MACRA)/implementation/Accountable Care Organizations
Medicare and Medicaid programs: MACRA/physician burdens
Medicare and Medicaid programs: Drug overdose epidemic
Medicare and Medicaid programs: 21st Century Cures 2.0
Medicare and Medicaid programs: Waste, fraud, and abuse in telehealth
Medicare and Medicaid programs: Prior authorization
Medicare and Medicaid programs: Public Option
Medicare and Medicaid programs: Electronic Health Records (EHR) certification
Medicare and Medicaid programs: Physician Health IT burdens
Medicare and Medicaid programs: Data privacy
Medicare and Medicaid programs: Provider compliance and regulatory relief
Medicaid program: COVID-19/Provider Relief Fund
Medicaid program: Funding for U.S. territories
Medicaid program: Medicaid expansion
Medicaid program: Work requirements
Medicaid program: COVID-19/Uninsured and healthcare coverage/child 12 month continuous eligibility
Medicaid program: Pediatric mental health care access/behavioral health services
Medicaid program: Special enrollment period
Medicaid program: Proprietary Laboratory Analysis (PLA) codes
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Natl Institute of Standards & Technology (NIST), Centers For Disease Control & Prevention (CDC), White House Office, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Jennifer |
McLaughlin |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Jason |
Scull |
|
|
|
Danielle |
Turnipseed |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Bryan |
Hull |
|
|
|
Alexis |
Pierce |
|
|
|
Kyle |
Thomson |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R. 2079, Eliminating the Provider Relief Fund Tax Penalties Act of 2021, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
George |
Cox |
III |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Flavored new tobacco products/FDA premarket review
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 3021, Coronavirus Provider Protection Act, all provisions
COVID-19/physician liability protections
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Christopher |
Sherin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
H.R. 958, Protecting Moms Who Served Act, all provisions
S. 796, Protecting Moms Who Served Act of 2021, all provisions
Scope of Practice
VA Supremacy Project
Veterans Choice/Community Care Program
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |